Page last updated: 2024-09-03

gp 1-515 and Colitis

gp 1-515 has been researched along with Colitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albrich, S; Bidlingmaier, C; Boyle, D; Eigler, A; Endres, S; Firestein, GS; Hartmann, G; Lehr, HA; Loher, F; Rieder, F; Siegmund, B; Wolf, K	1

Other Studies

1 other study(ies) available for gp 1-515 and Colitis

Article	Year
Adenosine kinase inhibitor GP515 improves experimental colitis in mice. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:1 Topics: Adenosine Kinase; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cells, Cultured; Colitis; Colon; Dextran Sulfate; Enzyme Inhibitors; Female; Flow Cytometry; Gastrointestinal Agents; Interferon-gamma; Lectins, C-Type; Mice; Mice, Inbred BALB C; Organ Size; Ribonucleosides; Spleen; Tetradecanoylphorbol Acetate	2001

Article

Year

Adenosine kinase inhibitor GP515 improves experimental colitis in mice.

The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:1

Topics: Adenosine Kinase; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cells, Cultured; Colitis; Colon; Dextran Sulfate; Enzyme Inhibitors; Female; Flow Cytometry; Gastrointestinal Agents; Interferon-gamma; Lectins, C-Type; Mice; Mice, Inbred BALB C; Organ Size; Ribonucleosides; Spleen; Tetradecanoylphorbol Acetate

2001